These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 1907291)
1. Determination of glibenclamide and its two major metabolites in human serum and urine by column liquid chromatography. Rydberg T; Wåhlin-Boll E; Melander A J Chromatogr; 1991 Mar; 564(1):223-33. PubMed ID: 1907291 [TBL] [Abstract][Full Text] [Related]
2. High-performance liquid chromatographic determination of glibenclamide in human plasma and urine. Emilsson H; Sjöberg S; Svedner M; Christenson I J Chromatogr; 1986 Nov; 383(1):93-102. PubMed ID: 3102535 [TBL] [Abstract][Full Text] [Related]
3. High-performance liquid column and thin-layer chromatographic determination of human serum glibenclamide at therapeutic levels. Uihlein M; Sistovaris N J Chromatogr; 1982 Jan; 227(1):93-101. PubMed ID: 6799533 [TBL] [Abstract][Full Text] [Related]
4. Validation of a sensitive LC-MS assay for quantification of glyburide and its metabolite 4-transhydroxy glyburide in plasma and urine: an OPRU Network study. Naraharisetti SB; Kirby BJ; Hebert MF; Easterling TR; Unadkat JD J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Dec; 860(1):34-41. PubMed ID: 17980680 [TBL] [Abstract][Full Text] [Related]
5. Comparison of the kinetics of glyburide and its active metabolites in humans. Rydberg T; Jönsson A; Melander A J Clin Pharm Ther; 1995 Oct; 20(5):283-95. PubMed ID: 8576296 [TBL] [Abstract][Full Text] [Related]
6. A rapid high-performance liquid chromatography assay of glibenclamide in serum. Abdel-Hamid ME; Suleiman MS; el-Sayed YM; Najib NM; Hasan MM J Clin Pharm Ther; 1989 Jun; 14(3):181-8. PubMed ID: 2503528 [TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of glibenclamide and its metabolites in diabetic patients with impaired renal function. Jönsson A; Rydberg T; Sterner G; Melander A Eur J Clin Pharmacol; 1998 Feb; 53(6):429-35. PubMed ID: 9551701 [TBL] [Abstract][Full Text] [Related]
8. Determination of glibenclamide in human plasma by solid-phase extraction and high-performance liquid chromatography. Valdes Santurio JR; González Porto E J Chromatogr B Biomed Appl; 1996 Jul; 682(2):364-70. PubMed ID: 8844432 [TBL] [Abstract][Full Text] [Related]
9. A validated high-performance liquid chromatographic method for the determination of glibenclamide in human plasma and its application to pharmacokinetic studies. Niopas I; Daftsios AC J Pharm Biomed Anal; 2002 May; 28(3-4):653-7. PubMed ID: 12008145 [TBL] [Abstract][Full Text] [Related]
10. Concentration-effect relations of glibenclamide and its active metabolites in man: modelling of pharmacokinetics and pharmacodynamics. Rydberg T; Jönsson A; Karlsson MO; Melander A Br J Clin Pharmacol; 1997 Apr; 43(4):373-81. PubMed ID: 9146849 [TBL] [Abstract][Full Text] [Related]
11. Quantitative determination of metformin, glyburide and its metabolites in plasma and urine of pregnant patients by LC-MS/MS. Zhang X; Wang X; Vernikovskaya DI; Fokina VM; Nanovskaya TN; Hankins GD; Ahmed MS Biomed Chromatogr; 2015 Apr; 29(4):560-9. PubMed ID: 25164921 [TBL] [Abstract][Full Text] [Related]
12. Determination of gliclazide in serum by high-performance liquid chromatography using solid-phase extraction. Noguchi H; Tomita N; Naruto S; Nakano S J Chromatogr; 1992 Dec; 583(2):266-9. PubMed ID: 1478992 [TBL] [Abstract][Full Text] [Related]
13. Liquid chromatographic determination of glibenclamide in human plasma. Othman S; Shaheen O; Jalal I; Awidi A; Al-Turk W J Assoc Off Anal Chem; 1988; 71(5):942-4. PubMed ID: 3148612 [TBL] [Abstract][Full Text] [Related]
14. Specific and sensitive high-performance liquid chromatographic determination of glyburide. Adams WJ; Krueger DS J Pharm Sci; 1979 Sep; 68(9):1138-40. PubMed ID: 115986 [TBL] [Abstract][Full Text] [Related]
15. High-performance liquid chromatographic determination of the nitroimidazole azanidazole in human plasma and urine. Brodie RR; Chasseaud LF; Walmsley LM; Darragh A; O'Kelly DA J Chromatogr; 1979 Nov; 179(2):301-9. PubMed ID: 541441 [TBL] [Abstract][Full Text] [Related]
16. Lack of relationship between glibenclamide metabolism and debrisoquine or mephenytoin hydroxylation phenotypes. Dahl-Puustinen ML; Alm C; Bertilsson L; Christenson I; Ostman J; Thunberg E; Wikström I Br J Clin Pharmacol; 1990 Sep; 30(3):476-80. PubMed ID: 2121211 [TBL] [Abstract][Full Text] [Related]
17. High-performance liquid chromatographic determination of lansoprazole and its metabolites in human serum and urine. Aoki I; Okumura M; Yashiki T J Chromatogr; 1991 Nov; 571(1-2):283-90. PubMed ID: 1810958 [TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics and relative bioavailability of tablet of micronized glibenclamide in 4 Chinese healthy men. Cui HD; Jiang WD; Zhu XX; Guo Y; Karras HO Zhongguo Yao Li Xue Bao; 1993 May; 14(3):193-7. PubMed ID: 8237389 [TBL] [Abstract][Full Text] [Related]
19. High-performance liquid chromatographic determination of seratrodast and its metabolites in human serum and urine. Ohta R; Amano T; Yamashita K; Motohashi M J Chromatogr B Biomed Sci Appl; 1997 Dec; 704(1-2):325-31. PubMed ID: 9518166 [TBL] [Abstract][Full Text] [Related]
20. Determination of bromazepam in plasma and of its main metabolites in urine by reversed-phase high-performance liquid chromatography. Heizmann P; Geschke R; Zinapold K J Chromatogr; 1984 Sep; 310(1):129-37. PubMed ID: 6150047 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]